EYLEA SOLUTION FOR INJECTION IN VIAL 2MG
Product details
Registration number: SIN14345P
Classification: Prescription Only
Active ingredients: Aflibercept
Strength: 2.0mg/50mcl
Dosage form: INJECTION, SOLUTION
Route: INTRAVITREOUS
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
ATC code: S01LA05
HSA approval date: 29 April 2013
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG (Langenargen)
- Bayer AG (Berlin)
- Regeneron Pharmaceuticals, Inc.
- Vetter Pharma-Fertigung GmbH & Co. KG (Ravensburg)
Manufacturing country/countries: UNITED STATES; GERMANY
What are the HSA registration number and classification for EYLEA SOLUTION FOR INJECTION IN VIAL 2MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14345P
Classification: Prescription Only
What active ingredients and strength are recorded for EYLEA SOLUTION FOR INJECTION IN VIAL 2MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Aflibercept
Strength: 2.0mg/50mcl
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for EYLEA SOLUTION FOR INJECTION IN VIAL 2MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAVITREOUS
Who is the recorded registrant for EYLEA SOLUTION FOR INJECTION IN VIAL 2MG?
According to the HSA dataset updated 7 August 2026:
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
Which manufacturers and countries are listed for EYLEA SOLUTION FOR INJECTION IN VIAL 2MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG (Langenargen)
- Bayer AG (Berlin)
- Regeneron Pharmaceuticals, Inc.
- Vetter Pharma-Fertigung GmbH & Co. KG (Ravensburg)
Manufacturing country/countries: UNITED STATES; GERMANY
Where can I look up EYLEA SOLUTION FOR INJECTION IN VIAL 2MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14345P or the exact product name EYLEA SOLUTION FOR INJECTION IN VIAL 2MG. The general register link does not preselect this product.
What are the source dates for this EYLEA SOLUTION FOR INJECTION IN VIAL 2MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this EYLEA SOLUTION FOR INJECTION IN VIAL 2MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14345P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)